Publication | Closed Access
O-157 Survival benefit of oral topotecan plus supportive care versus supportive care alone in relapsed, resistant SCLC
20
Citations
0
References
2005
Year
Resistant SclcMedicineO-157 Survival BenefitPharmacotherapyCancer TreatmentOncologyRadiation OncologyCancer ResearchOral Cancer
No additional data available for this publication yet. Check back later!